Pharmaceutical products: Crestor (rosuvastatin) and Nexium (esomeprazole)

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista Dossier about AstraZeneca and its top brands Crestor and Nexium

Table of contents

  • 1. Overview
    • AstraZeneca's top products based on revenue 2018-2020

    • AstraZeneca's revenue from top product Crestor 2006-2020

    • AstraZeneca's revenue from Crestor by region 2018-2020

    • Total savings of top generic drugs in U.S. 2020

    • AstraZeneca's revenue from top product Nexium 2006-2020

    • AstraZeneca's revenue from Nexium by region 2018-2020

    • Leading antacid tablet brands in the U.S. 2019, based on sales

    • Sales value of leading drugs Japan FY 2020

  • 2. Drug prices and consumer behavior
    • U.S. household expenditure on prescription drugs 2007-2019

    • Esomeprazole prescriptions number U.S. 2007-2018

    • Esomeprazole out of pocket cost U.S. 2004-2018

    • Rosuvastatin calcium out-of-pocket cost U.S. 2004-2018

    • Number of rosuvastatin calcium prescriptions in the U.S. 2004-2018

  • 3. Advertising expenditures
    • AstraZeneca: ad spend in the U.S. 2012-2019

    • Leading pharmaceutical companies in the U.S. 2020, by DTC

    • Pharma companies with largest print ad spend in the U.S. 2020

More than 7,500
companies
trust
Statista

Recommended studies and dossiers

Recent studies and dossiers

You may also be interested in...

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!